Zoetis | ZTS - Selling And Administration Expenses


Zoetis reported $588M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
AbbVie USD 3.58B 316M Mar/2026
Align Technology USD 465.34M 23.67M Mar/2026
Bayer EUR 3.7B 356M Mar/2026
Bristol-Myers Squibb USD 1.62B 564M Mar/2026
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Coherus Biosciences USD 15M 6.26M Dec/2025
Dentsply International USD 351M 32M Mar/2026
Eli Lilly USD 2.93B 198M Mar/2026
Henry Schein USD 809M 1000K Mar/2026
Idexx Laboratories USD 299.85M 24.18M Mar/2026
Illumina USD 272M 11M Mar/2026
IQVIA Holdings USD 502M 34M Mar/2026
J&J USD 6.03B 719M Mar/2026
Laboratory Of America USD 551M 12.4M Mar/2026
Merck USD 2.67B 180M Mar/2026
Neogen USD 98.5M 9M Dec/2025
Pacira USD 83.88M 7.99M Mar/2026
Perrigo USD 267.3M 11.4M Mar/2026
Pfizer USD 2.92B 1.16B Mar/2026
Phibro Animal Health USD 78.32M 10.24M Dec/2025
Quest Diagnostics USD 504M 0 Mar/2026
Sanofi EUR 2.33B 419M Mar/2026
Sanofi EUR 2.75B 455M Dec/2025
Zoetis USD 588M 31M Mar/2026